Clinical Trial Update: EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug [Phase 3]

View source ↗

Summary

Phase 3 trial assessing concurrent chemoradiotherapy with or without an antiviral drug for Epstein-Barr virus–positive nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• antiviral drug
• concurrent chemoradiotherapy

Snippet

Sponsor: Kuwait Cancer Control Center | Conditions: Drug Use for Unapproved Schedule | Phase 3 | Status: UNKNOWN